Inventor · disambiguated record
Melanie Ott
Also filed as: OTT MELANIE · OTT MELANIE N · OTT MÉLANIE
13 granted patents·18 pending applications·77 citations·filing 2000–2025
89Inventor score
Top patents by PatentIndex Score
31 records- 0186US7589167B2ZA loops of bromodomainsDAVID GLADSTONE INST J·Filed 2001·Granted Sep 15, 2009·33 cites·2 claims
- 0281US7482016B2Immunogenic compositions comprising HIV-1 acetylated Tat polypeptidesDAVID GLADSTONE INST·Filed 2004·Granted Jan 27, 2009·13 cites·26 claims
- 0379US11098309B2Compositions and methods for reactivating latent immunodeficiency virusTHE J DAVID GLADSTONE INST A TESTAMENTARY TRUST ESTABLISHED UNDER THE WILL OF J DAVID GLADSTONE·Filed 2019·Granted Aug 24, 2021·1 cites·9 claims
- 0479US10351853B2Compositions and methods for reactivating latent immunodeficiency virusTHE J DAVID GLADSTONE INST·Filed 2017·Granted Jul 16, 2019·3 cites·19 claims
- 0578US7485416B2Screening methods for the identification of agents that inhibit SIRT1 Tat deacetylase activityUNIV CALIFORNIA·Filed 2004·Granted Feb 3, 2009·6 cites·16 claims
- 0674US6445861B1Sol-gel processing to form doped sol-gel monoliths inside hollow core optical fiber and sol-gel core fiber devices made therebyNASA·Filed 2000·Granted Sep 3, 2002·18 cites·44 claims
- 0773US8748464B2Use of SIRT1 activators or inhibitors to modulate an immune responseVERDIN ERIC M·Filed 2010·Granted Jun 10, 2014·2 cites·7 claims
- 0871US11807852B2Compositions and methods for reactivating latent immunodeficiency virusTHE J DAVID GLADSTONE INST A TESTAMENTARY TRUST ESTABLISHED UNDER THE WILL OF J DAVID GLADSTONE·Filed 2021·Granted Nov 7, 2023·0 cites·7 claims
- 0968US2024318266A1High-throughput screening of sars-cov-2 variantsTHE J DAVID GLADSONE INST A TESTAMENTARY TRUST ESABLISHED UNDER THE WILL OF J DAVID GLADSTO·Filed 2024·Application pending·0 cites
- 1065US12215377B2HIV or HCV detection with CRISPR-CAS13AUNIV CALIFORNIA·Filed 2019·Granted Feb 4, 2025·0 cites·19 claims
- 1164US2024209381A1Rapid generation of infectious clonesTHE J DAVID GLADSTONE INST·Filed 2023·Application pending·0 cites
- 1262US2015098926A1Methods of Treating Hepatitis C Virus InfectionDAVID GLADSTONE INST·Filed 2014·Application pending·0 cites
- 1360US2025382658A1Hiv or hcv detection with crispr-cas13aTHE J DAVID GLADSTONE INST A TESTAMENTARY TRUST ESTABLISHED UNDER THE WILL OF J DAVID GLAD·Filed 2025·Application pending·0 cites
- 1459US10004751B2Compositions and methods for treating Dengue virus infectionTHE J DAVID GLADSTONE INST·Filed 2015·Granted Jun 26, 2018·1 cites·13 claims
- 1558US2024309473A1Kinetic barcoding to enhance specificity of crispr/cas reactionsTHE J DAVID GLADSTONE INST A TESTAMENTARY TRUST ESTABLISHED UNDER THE WELL OF J·Filed 2022·Application pending·0 cites
- 1655US8034350B2Methylated tat polypeptides and methods of use thereofDAVID GLADSTONE INST·Filed 2008·Granted Oct 11, 2011·0 cites·14 claims
- 1754US2024115466A1Process for preparing a shampoo from an anhydrous solid surfactant compositionOREAL·Filed 2021·Application pending·0 cites
- 1854US2024009099A1Anhydrous solid shampoo based on surfactants and on a fatty acid salt, its method of preparation and a kitOREAL·Filed 2021·Application pending·0 cites
- 1954US2025369058A1Viral Diagnostic using CRISPR RNA combinations and Cas13a enzymeTHE J DAVID GLADSTONE INST A TESTAMENTARY TRUST ESTABLISHED UNDER THE WILL OF J DAVID·Filed 2023·Application pending·0 cites
- 2053US2010160262A1Compositions and methods for modulating sirtuin activityOTT MELANIE·Filed 2008·Application pending·0 cites
- 2152US2014030295A1Use of Sirt1 Activators or Inhibitors to Modulate an Immune ResponseDAVID GLADSTONE INST·Filed 2012·Application pending·0 cites
- 2249US2015133434A1Compositions and Methods for Reactivating Latent Immunodeficiency VirusDAVID GLADSTONE INST·Filed 2013·Application pending·0 cites
- 2348US2024295544A1ASSAY FOR SARS-CoV-2 INFECTION OF VULNERABLE HUMAN CELLSTHE J DAVID GLADSTONE INST A TESTAMENTARY TRUST ESTABLISHED UNDER THE WILL OF J DAVID GLADS·Filed 2021·Application pending·0 cites
- 2448US2022193209A1Compositions and methods for reactivating latent immunodeficiency virus and/or treating immunodeficiency virus infectionTHE J DAVID GLADSTONE INST A TESTAMENTARY TRUST ESTABLISHED UNDER THE WILL OF J DAVID GLADS·Filed 2020·Application pending·0 cites
- 2546US2011243894A1Methods of treating hepatitis c virus infectionOTT MELANIE·Filed 2011·Application pending·0 cites
- 2644US2012028912A1Methods of modulating bromodomainsZHOU MING-MING·Filed 2009·Application pending·0 cites
- 2743US2011110891A1Methods of Treating Hepatitis C Virus InfectionOTT MELANIE·Filed 2009·Application pending·0 cites
- 2839US10036632B2System to perform radio frequency interferometry using optical fiber sensing signal processing techniquesNASA·Filed 2016·Granted Jul 31, 2018·0 cites·18 claims
- 2939US2004009613A1Methods of identifying modulators of bromodomainsFiled 2002·Application pending·0 cites
- 3035US8580492B2Screening method for the identification of inhibitors of HIV Tat methylation by the lysine methyltransferase Set7/9OTT MELANIE·Filed 2011·Granted Nov 12, 2013·0 cites·8 claims
- 3130US2012108500A1Compositions and Methods for Modulating Immunodeficiency Virus TranscriptionSAKANE NAOKI·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Melanie Ott files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →